Bench-to-bedside review: Critical illness-associated cognitive dysfunction - Mechanisms, markers, and emerging therapeutics

Critical Care

Volumn 10, Issue 6, 2006, Pages

  Milbrandt, Eric B ^a   Angus, Derek C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; CYCLOSPORIN A; DEXMEDETOMIDINE; DIGOXIN; DISUFENTON SODIUM; DONEPEZIL; FENTANYL; FUROSEMIDE; GABAPENTIN; GLUCOCORTICOID; HALOPERIDOL; HISTAMINE H2 RECEPTOR ANTAGONIST; INTRAVENOUS ANESTHETIC AGENT; MIDAZOLAM; MYELIN BASIC PROTEIN; NEURON SPECIFIC ENOLASE; OPIATE DERIVATIVE; PLACEBO; PROPOFOL; PROTEIN S100B; PYRUVIC ACID; RECOMBINANT ERYTHROPOIETIN; SEROTONIN AGONIST; SEROTONIN UPTAKE INHIBITOR; SEVOFLURANE; SIMVASTATIN; TRICYCLIC ANTIDEPRESSANT AGENT; XENON; BIOLOGICAL MARKER;

ADD ON THERAPY; AGITATION; ALZHEIMER DISEASE; ANTICHOLINERGIC EFFECT; ARTIFICIAL VENTILATION; BRAIN INJURY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE REHABILITATION; CRITICAL ILLNESS; DELIRIUM; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG SAFETY; HUMAN; INDUCED HYPOTHERMIA; INTENSIVE CARE; INTENSIVE CARE PSYCHOSIS; PATIENT CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; REVIEW; SEPSIS; SEROTONIN SYNDROME; SPINE SURGERY; UNSPECIFIED SIDE EFFECT; BRAIN INJURY, CHRONIC; COGNITION DISORDERS; COMPLICATION; PATHOPHYSIOLOGY;

BIOLOGICAL MARKERS; BRAIN INJURY, CHRONIC; COGNITION DISORDERS; CRITICAL ILLNESS; HUMANS;

EID: 34447628066     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc5078     Document Type: Review

References (111)

1. Martin GS Mannino DM Eaton S Moss M The epidemiology of sepsis in the United States from 1979 through 2000 N Engl J Med 2003 348 1546-1554 10.1056/NEJMoa022139 12700374
2. Milberg JA Davis DR Steinberg KP Hudson LD Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993 JAMA 1995 273 306-309 10.1001/jama.273.4.306 7815658
3. Hopkins RO Weaver LK Collingridge D Parkinson RB Chan KJ Orme JF Jr Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome Am J Respir Crit Care Med 2005 171 340-347 10.1164/rccm.200406-763OC 15542793
4. Fried TR Bradley EH Towle VR Allore H Understanding the treatment preferences of seriously ill patients N Engl J Med 2002 346 1061-1066 10.1056/NEJMsa012528 11932474
5. Milbrandt EB Angus DC Potential mechanisms and markers of critical illness-associated cognitive dysfunction Curr Opin Crit Care 2005 11 355-359 10.1097/01.ccx.0000170508.63067.04 16015116
6. Ely EW Inouye SK Bernard GR Gordon S Francis J May L Truman B Speroff T Gautam S Margolin R Hart RP Dittus R Delirium in mechanically ventilated patients: Validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU) Jama 2001 286-2703 10 10.1001/ jama.286.21.2703 11730446
7. Ely W Gautam S Margolin R Francis J May L Speroff T Truman B Dittus R Bernard R Inouye K The impact of delirium in the intensive care unit on hospital length of stay Intensive Care Med 2001 27 1892-1900 10.1007/ s00134-001-1132-2 11797025
8. Ely EW Shintani A Truman B Speroff T Gordon SM Harrell FE Jr Inouye SK Bernard GR Dittus RS Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit Jama 2004 291 1753-1762 10.1001/jama.291.14.1753 15082703
9. Milbrandt EB Deppen S Harrison PL Shintani AK Speroff T Stiles RA Truman B Bernard GR Dittus RS Ely EW Costs associated with delirium in mechanically ventilated patients Crit Care Med 2004 32 955-962 10.1097/ 01.CCM.0000119429.16055.92 15071384
10. Kiely DK Bergmann MA Murphy KM Jones RN Orav EJ Marcantonio ER Delirium among newly admitted postacute facility patients: Prevalence, symptoms, and severity J Gerontol A Biol Sci Med Sci 2003 58 M441-M445 12730254
11. Levkoff SE Evans DA Liptzin B Cleary PD Lipsitz LA Wetle TT Reilly CH Pilgrim DM Schor J Rowe J Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients Arch Intern Med 1992 152 334-40 10.1001/archinte.152.2.334 1739363
12. Marcantonio ER Simon SE Bergmann MA Jones RN Murphy KM Morris JN Delirium symptoms in post-acute care: Prevalent, persistent, and associated with poor functional recovery J Am Geriatr Soc 2003 51 4-9 10.1034/j.1601-5215.2002.51002.x 12534838
13. McNicoll L Pisani MA Zhang Y Ely EW Siegel MD Inouye SK Delirium in the intensive care unit: Occurrence and clinical course in older patients J Am Geriatr Soc 2003 51 591-598 10.1034/j.1600-0579.2003.00201.x 12752832
14. Girard T Jackson JC Pun BT Ely EW Shintani A Renfrew JW Dunn J Laskowitz DT Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in humans Crit Care Med 2006 33 A22 10.1097/ 00003246-200512002-00086
15. Inouye SK Delirium in older persons N Engl J Med 2006 354 1157-1165 10.1056/NEJMra052321 16540616
16. Mulsant BH Pollock BG Kirshner M Shen C Dodge H Ganguli M Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance Arch Gen Psychiatry 2003 60 198-203 10.1001/archpsyc.60.2.198 12578438
17. Carnahan RM Lund BC Perry PJ Pollock BG A critical appraisal of the utility of the serum anticholinergic activity assay in research and clinical practice Psychopharmacol Bull 2002 36 24-39 12397838
18. Pratico C Quattrone D Lucanto T Amato A Penna O Roscitano C Fodale V Drugs of anesthesia acting on central cholinergic system may cause post-operative cognitive dysfunction and delirium Med Hypotheses 2005 65 972-982 10.1016/j.mehy.2005.05.037 16043305
19. Flacker JM Wei JY Endogenous anticholinergic substancesmay exist during acute illness in elderly medical patients J Gerontol A Biol Sci Med Sci 2001 56 M353-M355 11382794
20. Czura CJ Friedman SG Tracey KJ Neural inhibition of inflammation: The cholinergic anti-inflammatory pathway J Endotoxin Res 2003 9 409-413 10.1179/096805103225002755 14733730
21. Carnahan RM Lund BC Perry PJ Culp KR Pollock BG The relationship of an anticholinergic rating scale with serum anti-cholinergic activity in elderly nursing home residents Psychopharmacol Bull 2002 36 14-19 12858139
22. Carnahan RM Lund BC Perry PJ Culp KR Pollock BG Comparing models for estimating anticholinergic burden from medications using serum anticholinergic activity as the gold standard Pharmacotherapy 2006 25 1496-1497
23. Tune L Coyle JT Serum levels of anticholinergic drugs in treatment of acute extrapyramidal side effects Arch Gen Psychiatry 1980 37 293-297 6102457
24. Tune LE Damlouji NF Holland A Gardner TJ Folstein MF Coyle JT Association of postoperative delirium with raised serum levels of anticholinergic drugs Lancet 1981 2 651-653 10.1016/ S0140-6736(81)90994-6 6116042
25. Flacker JM Cummings V Mach JR Jr Bettin K Kiely DK Wei J The association of serum anticholinergic activity with delirium in elderly medical patients Am J Geriatr Psychiatry 1998 6 31-41 9469212
26. Inouye SK van Dyck CH Alessi CA Balkin S Siegal AP Horwitz RI Clarifying confusion: The confusion assessment method. A new method for detection of delirium Ann Intern Med 1990 113 941-8 2240918
27. Mussi C Ferrari R Ascari S Salvioli G Importance of serum anticholinergic activity in the assessment of elderly patients with delirium J Geriatr Psychiatry Neurol 1999 12 82-86 10483930
28. Golinger RC Peet T Tune LE Association of elevated plasma anticholinergic activity with delirium in surgical patients Am J Psychiatry 1987 144 1218-1220 3631323
29. Sommer BR Wise LC Kraemer HC Is dopamine administration possibly a risk factor for delirium? Crit Care Med 2002 30 1508-1511 10.1097/ 00003246-200207000-00019 12130971
30. Boyer EW Shannon M The serotonin syndrome N Engl J Med 2005 352 1112-1120 10.1056/NEJMra041867 15784664
31. Fischer JE Rosen HM Ebeid AM James JH Keane JM Soeters PB The effect of normalization of plasma amino acids on hepatic encephalopathy in man Surgery 1976 80 77-91 818729
32. Glue P Nutt D Overexcitement and disinhibition. Dynamic neurotransmitter interactions in alcohol withdrawal Br J Psychiatry 1990 157 491-499 1983388
33. Gaudreau JD Gagnon P Roy MA Harel F Tremblay A Association between psychoactive medications and delirium in hospitalized patients: A critical review Psychosomatics 2005 46 302-316 10.1176/appi.psy.46.4.302 16000673
34. Pandharipande P Ely EW Sedative and analgesicmedications: Risk factors for delirium and sleep disturbances in the critically ill Crit Care Clin 2006 22 313-27 vii 16678002
35. Pandharipande P Shintani A Peterson J Pun BT Wilkinson GR Dittus RS Bernard GR Ely EW Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients Anesthesiology 2006 104 21-26 10.1097/00000542-200601000-00005 16394685
36. Kress JP Pohlman AS O'Connor MF Hall JB Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation N Engl J Med 2000 342 1471-7 10.1056/NEJM200005183422002 10816184
37. Ancelin ML de Roquefeuil G Ledesert B Bonnel F Cheminal JC Ritchie K Exposure to anaesthetic agents, cognitive functioning and depressive symptomatology in the elderly Br J Psychiatry 2001 178 360-366 10.1192/ bjp.178.4.360 11282816
38. Dodds C Allison J Postoperative cognitive deficit in the elderly surgical patient Br J Anaesth 1998 81 449-462 9861139
39. Crippen D Agitation in the ICU: Part one - anatomical and physiologic basis for the agitated state Crit Care (Lond) 1999 3 R35-R46 137231 11094481 10.1186/cc348
40. Flacker JM Lipsitz LA Neural mechanisms of delirium: Current hypotheses and evolving concepts J Gerontol A Biol Sci Med Sci 1999 54 B239-B246 10411009
41. van der Mast RC Pathophysiology of delirium J Geriatr Psychiatry Neurol 1998 11 138-145 9894732
42. Orlikowski D Sharshar T Annane D The brain in sepsis Adv Sepsis 2003 3 8-14
43. Barichello T Fortunato JJ Vitali AM Feier G Reinke A Moreira JC Quevedo J Dal Pizzol F Oxidative variables in the rat brain after sepsis induced by cecal ligation and perforation Crit Care Med 2006 34 886-889 10.1097/ 01.CCM.0000201880.50116.12 16505668
44. Christenson JT Kuikka JT Owunwanne A Al-Sarraf AA Cerebral circulation during endotoxic shock with special emphasis on the regional cerebral blood flow in vivo Nucl Med Commun 1986 7 531-540 3774252
45. Ekstrom-Jodal B Haggendal J Larsson LE Westerlind A Cerebral hemodynamics, oxygen uptake and cerebral arteriove-nous differences of catecholamines following E. coli endotoxin in dogs Acta Anaesthesiol Scand 1982 26 446-452 6756018
46. Ekstrom-Jodal B Haggendal E Larsson LE Cerebral blood flow and oxygen uptake in endotoxic shock. An experimental study in dogs Acta Anaesthesiol Scand 1982 26 163-170 6810643
47. Parker JL Emerson TE Jr Cerebral hemodynamics, vascular reactivity, and metabolism during canine endotoxin shock Circ Shock 1977 4 41-53 923008
48. Rudinsky BF Lozon M Bell A Hipps R Meadow WL Group B streptococcal sepsis impairs cerebral vascular reactivity to acute hypercarbia in piglets Pediatr Res 1996 39 55-63 8825386
49. Gray F Sharshar T De La Grandmaison GL Annane D Neuropathology of septic shock Neuropathol Appl Neurobiol 2002 28 159 10.1046/ j.1365-2990.2002.39286_30.x
50. Sharshar T Gray F Poron F Raphael JC Gajdos P Annane D Multifocal necrotizing leukoencephalopathy in septic shock Crit Care Med 2002 30 2371-2375 10.1097/00003246-200210000-00031 12394971
51. Sharshar T Gray F Lorin de la Grandmaison G Hopkinson NS Ross E Dorandeu A Orlikowski D Raphael JC Gajdos P Annane D Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock Lancet 2003 362 1799-1805 10.1016/ S0140-6736(03)14899-4 14654318
52. Sharshar T Annane D De La Grandmaison GL Brouland JP Hopkinson NS Francoise G The neuropathology of septic shock Brain Pathol 2004 14 21-33 14997934
53. Wijdicks EF Stevens M The role of hypotension in septicencephalopathy following surgical procedures Arch Neurol 1992 49 653-656 1596202
54. Maekawa T Fujii Y Sadamitsu D Yokota K Soejima Y Ishikawa T Miyauchi Y Takeshita H Cerebral circulation and metabolism in patients with septic encephalopathy Am J Emerg Med 1991 9 139-143 10.1016/ 0735-6757(91)90175-J 1994941
55. Beloosesky Y Grinblat J Pirotsky A Weiss A Hendel D Different C-reactive protein kinetics in post-operative hip-fractured geriatric patients with and without complications Gerontology 2004 50 216-222 10.1159/000078350 15258426
56. Karlidag R Unal S Sezer OH Bay KA Battaloglu B But A Ozcan C The role of oxidative stress in postoperative delirium Gen Hosp Psychiatry 2006 28 418-423 10.1016/j.genhosppsych.2006.06.002 16950378
57. Yokota H Ogawa S Kurokawa A Yamamoto Y Regional cerebral blood flow in delirium patients Psychiatry Clin Neurosci 2003 57 337-339 10.1046/ j.1440-1819.2003.01126.x 12753576
58. Hopkins RO Weaver LK Pope D Orme JF Bigler ED Larson-Lohr V Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome Am J Respir Crit Care Med 1999 160 50-56 10390379
59. Hopkins RO Suchyta MR Jephson A Hyperglycemia and neurocognitive outcome in ARDS survivors [abstract] Am J Respir Crit Care Med 2005 2 A36
60. Chew W Kucharczyk J Moseley M Derugin N Norman D Hyperglycemia augments ischemic brain injury: In vivo MR imaging/spectroscopic study with nicardipine in cats with occluded middle cerebral arteries AJNR Am J Neuroradiol 1991 12 603-609 1882734
61. Aberg T Signs of brain cell injury during open heart operations: Past and present Ann Thorac Surg 1995 59 1312-1315 10.1016/ 0003-4975(95)00194-P 7733759
62. Herrmann M Vos P Wunderlich MT de Bruijn CH Lamers KJ Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein Stroke 2000 31 2670-2677 11062293
63. Svenmarker S Sandstrom E Karlsson T Aberg T Is there an association between release of protein S100B during car-diopulmonary bypass and memory disturbances? Scand Cardiovasc J 2002 36 117-122 10.1080/ 140174302753675410 12028876
64. Jonsson H Johnsson P Alling C Westaby S Blomquist S Significance of serum S100 release after coronary artery bypass grafting Ann Thorac Surg 1998 65 1639-1644 10.1016/S0003-4975(98)00229-X 9647073
65. Hardemark HG Ericsson N Kotwica Z Rundstrom G Mendel-Hartvig I Olsson Y Pahlman S Persson L S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage J Neurosurg 1989 71 727-731 2809727
66. Raabe A Grolms C Keller M Dohnert J Sorge O Seifert V Correlation of computed tomography findings and serum brain damage markers following severe head injury Acta Neurochir (Wien) 1998 140 787-791 10.1007/ s007010050180 9810445
67. Raabe A Grolms C Sorge O Zimmermann M Seifert V Serum S-100B protein in severe head injury Neurosurgery 1999 45 477-483 10.1097/ 00006123-199909000-00012 10493369
68. Ingebrigtsen T Romner B Biochemical serum markers for brain damage: A short review with emphasis on clinical utility in mild head injury Restor Neurol Neurosci 2003 21 171-176 14530579
69. Routsi C Stamataki E Nanas S Psachoulia C Zervou M Koro-neos A Stathopoulos A Roussos C Increased levels of serum S100B protein in critically ill patients without brain injury [poster presentation] Crit Care 2005 Suppl 1 P289 10.1186/cc3352
70. Lipcsey M Larsson A Sjolin J Hansson L Eriksson M Blood-brain barrier damage is an early event in porcine endotoxemic shock [poster presentation] Crit Care 2005 Suppl 1 P278 10.1186/cc3341
71. Fries M Bickenbach J Henzler D Beckers S Dembinski R Sell-haus B Rossaint R Kuhlen R S-100 protein and neuro-histopathologic changes in a porcine model of acute lung injury Anesthesiology 2005 102 761-767 10.1097/00000542-200504000-00011 15791105
72. Van Eldik LJ Wainwright MS The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain Restor Neurol Neurosci 2003 21 97-108 14530573
73. Dauberschmidt R Marangos PJ Zinsmeyer J Bender V Klages G Gross J Severe head trauma and the changes of concentration of neuron-specific enolase in plasma and in cere-brospinal fluid Clin Chim Acta 1983 131 165-170 10.1016/0009-8981(83)90085-2 6883712
74. Yamazaki Y Yada K Morii S Kitahara T Ohwada T Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury Surg Neurol 1995 43 267-270 10.1016/ 0090-3019(95)80012-6 7540773
75. Skogseid IM Nordby HK Urdal P Paus E Lilleaas F Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage Acta Neurochir (Wien) 1992 115 106-111 10.1007/BF01406367 1605077
76. Weigand MA Volkmann M Schmidt H Martin E Bohrer H Bar-denheuer HJ Neuron-specific enolase as a marker of fatal outcome in patients with severe sepsis or septic shock Anesthesiology 2000 92 905-907 10.1097/ 00000542-200003000-00057 10719986
77. Thomas DG Palfreyman JW Ratcliffe JG Serum-myelin-basic-protein assay in diagnosis and prognosis of patients with head injury Lancet 1978 1 113-115 10.1016/S0140-6736(78)90415-4 87549
78. Thomas DG Rabow L Teasdale G Serum myelin basic protein, clinical responsiveness, and outcome of severe head injury Acta Neurochir Suppl (Wien) 1979 28 93-95 90450
79. Jackson AC Gilbert JJ Young GB Bolton CF The encephalopathy of sepsis Can J Neurol Sci 1985 12 303-307 4084865
80. Young B Neurologic complications of systemic critical illness Neurologic Clinics 1995 13 645-658 7476822
81. Hopkins RO Gale SD Weaver LK Brain atrophy and cognitive impairment in survivors of acute respiratory distress syndrome Brain Inj 2006 20 263-271 10.1080/02699050500488199 16537268
82. Boada FE Gillen JS Shen GX Chang SY Thulborn KR Fast three dimensional sodium imaging Magn Reson Med 1997 37 706-715 9126944
83. Clayton DB Lenkinski RE MR imaging of sodium in thehuman brain with a fast three-dimensional gradient-recalled-echo sequence at 4 T Acad Radiol 2003 10 358-365 10.1016/S1076-6332(03)80023-5 12678174
84. Constantinides CD Kraitchman DL O'Brien KO Boada FE Gillen J Bottomley PA Noninvasive quantification of total sodium concentrations in acute reperfused myocardial infarction using 23Na MRI Magn Reson Med 2001 46 1144-1151 10.1002/mrm.1311 11746581
85. Hancu I Boada FE Shen GX Three-dimensional triple-quantum-filtered (23)Na imaging of in vivo human brain Magn Reson Med 1999 42 1146-1154 10.1002/(SICI)1522-2594(199912)42:6<1146::AID-MRM20>3.0.CO;2-S 10571937
86. Lin SP Song SK Miller JP Ackerman JJ Neil JJ Direct, longitudinal comparison of (1)H and (23)Na MRI after transient focal cerebral ischemia Stroke 2001 32 925-932 11283393
87. LaVerde GC Boada FE Davis D Nemoto E Jungreis CA Sodium MRI of reversible focal brain inchemia in the monkey [abstract] International Society for Magnetic Resonance in Medicine 12th Scientific Meeting and Exhibition 2004, Abstract number 1695. Proceedings of the 12th Scientific Meeting of the International Society for Magnetic Resonance in Medicine. 15-21 May 2004. Kyoto International Conference Hall, Kyoto, Japan. Mira Digital Publishing. St. Louis, MO
88. Thulborn KR Gindin TS Davis D Erb P Comprehensive MRimaging protocol for stroke management: Tissue sodium concentration as a measure of tissue viability in nonhuman primate studies and in clinical studies Radiology 1999 213 156-166 10540656
89. Lin SP Song SK Miller JP Ackerman JJ Neil JJ Direct, longitudinal comparison of (1)H and (23)Na MRI after transient focal cerebral ischemia Stroke 2001 32 925-932 11283393
90. Jacobi J Fraser GL Coursin DB Riker RR Fontaine D Wittbrodt ET Chalfin DB Masica MF Bjerke HS Coplin WM Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult Crit Care Med 2002 30 119-41 10.1097/00003246-200201000-00020 11902253
91. Kalisvaart KJ de Jonghe JF Bogaards MJ Vreeswijk R Egberts TC Burger BJ Eikelenboom P van Gool WA Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: A randomized placebo-controlled study J Am Geriatr Soc 2005 53 1658-1666 16181163
92. Milbrandt EB Kersten A Kong L Weissfeld LA Clermont G Dremsizov T Fink MP Angus DC Haloperidol use in mechanically ventilated patients is associated with lower hospital mortality Crit Care Med 2005 33 226-229 10.1097/01.CCM.0000150743.16005.9A 15644675
93. Leung JM Sands LP Rico M Petersen KL Rowbotham MC Dahl JB Ames C Chou D Weinstein P Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients Neurology 2006 67 1251-1253 10.1212/ 01.wnl.0000233831.87781.a9 16914695
94. Sampson EL Raven PR Ndhlovu PN Vallance A Garlick N Watts J Blanchard MR Bruce A Blizard R Ritchie CW A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement Int J Geriatr Psychiatry 2006 17006875
95. Maldonado JR van der Starre P Wysong A Block T Dexmedetomidine: Can it reduce the incidence of ICU delirium in postcardiotomy patients? Psychosomatics 2004 45 173
96. Bernaudin M Marti HH Roussel S Divoux D Nouvelot A MacKenzie ET Petit E A potential role for erythropoietin in focal permanent cerebral ischemia in mice J Cereb Blood Flow Metab 1999 19 643-651 10.1097/ 00004647-199906000-00007 10366194
97. Brines ML Ghezzi P Keenan S Agnello D de Lanerolle NC Cerami C Itri LM Cerami A Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury Proc Natl Acad Sci USA 2000 97 10526-10531 27058 10984541 10.1073/pnas.97.19.10526
98. Grasso G Buemi M Alafaci C Sfacteria A Passalacqua M Sturiale A Calapai G De Vico G Piedimonte G Salpietro FM Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage Proc Natl Acad Sci USA 2002 99 5627-5631 122821 11943864 10.1073/pnas.082097299
99. Leist M Ghezzi P Grasso G Bianchi R Villa P Fratelli M Savino C Bianchi M Nielsen J Gerwien J Derivatives of erythropoietin that are tissue protective but not erythropoietic Science 2004 305 239-242 10.1126/ science.1098313 15247477
100. Ma D Yang H Lynch J Franks NP Maze M Grocott HP Xenon attenuates cardiopulmonary bypass-induced neurologic andneurocognitive dysfunction in the rat Anesthesiology 2003 98 690-698 10.1097/ 00000542-200303000-00017 12606913
101. Jungwirth B Gordan ML Blobner M Schmehl W Kochs EF Mackensen GB Xenon impairs neurocognitive and histologic outcome after cardiopulmonary bypass combined with cerebral air embolism in rats Anesthesiology 2006 104 770-776 10.1097/00000542-200604000-00022 16571973
102. Lees KR Zivin JA Ashwood T Davalos A Davis SM Diener HC Grotta J Lyden P Shuaib A Hardemark HG Wasiewski WW NXY-059 for acute ischemic stroke N Engl J Med 2006 354 588-600 10.1056/NEJMoa052980 16467546
103. Montaner J Chacon P Krupinski J Rubio F Millan M Escudero D Hereu P Molina C Quintana M Alvarez-Sabin J Safety and efficacy of statin in the acute phase of ischemic stroke: The MISTICS Trial [Abstract] Stroke 2004 35 293
104. Yu YM Kim JB Lee KW Kim SY Han PL Lee JK Inhibition of the cerebral ischemic injury by ethyl pyruvate with a wide therapeutic window Stroke 2005 36 2238-2243 10.1161/01.STR.0000181779.83472.35 16141417
105. Alessandri B Rice AC Levasseur J DeFord M Hamm RJ Bullock MR Cyclosporin A improves brain tissue oxygen consumption and learning/memory performance after lateral fluid percussion injury in rats J Neurotrauma 2002 19 829-841 10.1089/08977150260190429 12184853
106. Shankaran S Laptook AR Ehrenkranz RA Tyson JE McDonald SA Donovan EF Fanaroff AA Poole WK Wright LL Higgins RD Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy N Engl J Med 2005 353 1574-1584 10.1056/NEJMcps050929 16221780
107. Hypothermia after Cardiac Arrest Study Group Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest N Engl J Med 2002 346 549-556 10.1056/NEJMoa012689 11856793
108. Bernard SA Gray TW Buist MD Jones BM Silvester W Gutteridge G Smith K Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia N Engl J Med 2002 346 557-563 10.1056/NEJMoa003289 11856794
109. Polderman KH Rijnsburger ER Peerdeman SM Girbes ARJ Induction of hypothermia in patients with various types of neurologic injury with use of large volumes of ice-cold intravenous fluid Crit Care Med 2005 33 2744-2751 10.1097/01.CCM.0000190427.88735.19 16352954
110. Kaplan CP Anoxic-hypotensive brain injury: Neuropsychological performance at 1 month as an indicator of recovery Brain Inj 1999 13 305-310 10.1080/026990599121674 10230531
111. Hopkins RO Brett S Chronic neurocognitive effects of critical illness Curr Opin Crit Care 2005 11 369-375 10.1097/01.ccx.0000166399.88635.a5 16015118